STAINER, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 450
EU - Europa 236
AS - Asia 132
AF - Africa 40
SA - Sud America 7
OC - Oceania 1
Totale 866
Nazione #
US - Stati Uniti d'America 447
CN - Cina 61
FI - Finlandia 50
SG - Singapore 48
IT - Italia 39
NG - Nigeria 39
IE - Irlanda 33
DE - Germania 26
FR - Francia 20
SE - Svezia 19
MK - Macedonia 17
GB - Regno Unito 10
IN - India 8
PH - Filippine 7
RU - Federazione Russa 6
JP - Giappone 4
NL - Olanda 4
UA - Ucraina 4
AR - Argentina 3
CA - Canada 3
PL - Polonia 3
BR - Brasile 2
CH - Svizzera 2
TR - Turchia 2
AU - Australia 1
CL - Cile 1
HR - Croazia 1
IL - Israele 1
NO - Norvegia 1
RS - Serbia 1
SA - Arabia Saudita 1
UG - Uganda 1
VE - Venezuela 1
Totale 866
Città #
Chandler 96
Boardman 57
Shanghai 57
New York 54
Helsinki 50
Benin City 39
Dublin 33
Ashburn 31
Singapore 29
Lawrence 24
Princeton 24
Paris 20
Milan 18
London 9
Skopje 9
Pune 7
Sacramento 7
Bitola 5
Frankfurt am Main 5
Los Angeles 5
Leawood 4
Santa Clara 4
Seattle 4
Amsterdam 3
Buenos Aires 3
Olongapo City 3
Prilep 3
St Petersburg 3
Winnipeg 3
Asagayakita 2
Gdansk 2
Henderson 2
Johnson City 2
Las Pinas 2
Phoenix 2
Rome 2
Sale Marasino 2
Venegono Superiore 2
Ankara 1
Cagayan de Oro 1
Canberra 1
Falkenstein 1
Florence 1
Gallarate 1
Heeten 1
Irving 1
Matsuyama 1
Moscow 1
Oslo 1
Riyadh 1
San Mateo 1
Sindelfingen 1
São Paulo 1
Tandag 1
Tel Aviv 1
Tianjin 1
Wilmington 1
Yoshizuka 1
Zagreb 1
Totale 648
Nome #
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 135
COVID-19 in Immunocompromised Patients: A Systematic Review 45
One-year pulmonary impairment after severe COVID-19: a prospective, multicenter follow-up study 39
Lung Microbiome in Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 34
Feasibility of CPAP application and variables related to worsening of respiratory failure in pregnant women with SARS-CoV-2 pneumonia: Experience of a tertiary care centre 33
Management of Chronic Respiratory Failure in Interstitial Lung Diseases: Overview and Clinical Insights 30
Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma 30
Characterizing non-tuberculous mycobacteria infection in bronchiectasis 28
Interstitial Pneumonia with Autoimmune Features: Why Rheumatologist-Pulmonologist Collaboration Is Essential 27
Macrolidi a lungo termine nella broncopneumopatia cronica ostruttiva 27
Molecular Biomarkers in Idiopathic Pulmonary Fibrosis: State of the Art and Future Directions 27
Diffuse alveolar haemorrhage associated with subsequent development of ANCA positivity and emphysema in three young adults 27
An unusual presentation of pulmonary lymphoma: When diffuse ground glass opacities can mean anything 26
Cardiovascular Complications in Community-Acquired Pneumonia 24
Non-tuberculous mycobacteria pulmonary disease: an integrated approach beyond antibiotics 22
Differences between Acute Exacerbations of Idiopathic Pulmonary Fibrosis and Other Interstitial Lung Diseases 22
Early or delayed bronchoscopy in patients admitted to the emergency department for mild-to-moderate hemoptysis? 21
Positive end expiratory pressure in acute hypoxemic respiratory failure due to community acquired pneumonia: Do we need a personalized approach? 21
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 21
Treatable traits in interstitial lung diseases: a call to action 20
Comparison of different sets of immunological tests to identify treatable immunodeficiencies in adult bronchiectasis patients 20
Non-tuberculous Mycobacterial Pulmonary Disease: an Italian National Survey 20
Non-specific interstitial pneumonia and features of connective tissue disease: What are the consequences of a different point of view? 20
Alpha1-Antitrypsin Inherited Variants in Patients With Bronchiectasis 19
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 19
Genetic and Serum Screening for Alpha-1-Antitrypsin Deficiency in Adult Patients with Cystic Fibrosis: A Single-Center Experience 17
Response to: Comment on "Noninvasive Ventilation Weaning in Acute Hypercapnic Respiratory Failure due to COPD Exacerbation: A Real-Life Observational Study" 16
Hepatic and pulmonary involvement in a patient with PR3-ANCA vasculitis following SARS-CoV-2 vaccination: a case report 15
Noninvasive ventilation weaning in acute hypercapnic respiratory failure due to COPD exacerbation: A real-life observational study 15
Systemic Sclerosis Associated Interstitial Lung Disease: A Comprehensive Overview 15
Efficacy of Pirfenidone and Nintedanib in Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis: A Systematic Review 14
Identify Drug-Resistant Pathogens in Patients with Community-Acquired Pneumonia 12
Unmet needs and perspectives in rheumatoid arthritis-associated interstitial lung disease: A critical review 11
Six-Month Pulmonary Impairment after Severe COVID-19: A Prospective, Multicentre Follow-Up Study 10
Microbial Inflammatory Networks in Bronchiectasis Exacerbators With Pseudomonas aeruginosa 9
Walking the path of treatable traits in interstitial lung diseases 8
Response to: are there over 200 distinct types of interstitial lung diseases? 7
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis 7
Long-Term Outcomes in Severe Community-Acquired Pneumonia 5
Diagnostic delay in bronchiectasis: an Italian perspective 4
First Report of the Prevalence at Baseline and after 1-Year Follow-Up of Treatable Traits in Interstitial Lung Diseases 4
Treatable Traits in Systemic Sclerosis 3
Immunodeficiencies and CFTR dysfunction: results from a systematic screening in a cohort of adults with cystic fibrosis and CFTR-related disorders 2
Vasoactive drugs for the treatment of pulmonary hypertension associated with interstitial lung diseases: a systematic review 2
Totale 933
Categoria #
all - tutte 9.858
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.858


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 0 11
2021/2022102 0 0 0 1 0 0 1 1 23 42 30 4
2022/2023350 51 11 44 7 37 21 17 29 58 41 27 7
2023/2024425 37 15 66 41 10 72 31 17 18 17 40 61
2024/202545 11 6 9 14 5 0 0 0 0 0 0 0
Totale 933